Sunil Healthcare Share Price
79.99+1.80 (+2.30%)
+8.02% past 1 Year
Sunloc, a leading brand of Empty Hard Gelatine Capsules, comes from Sunil Healthcare Ltd. Sunil Healthcare, having started its operations over three decades ago, is the second largest manufacturer of
Corporate filings & documents
Announcements
Copy of newspaper publications about dispatch of 52nd AGM Notice and Annual Report 2025-26 to shareholders of Company including book closure intimation etc.
1 day agoCopy of newspaper publications about dispatch of 52nd AGM Notice and Annual Report 2025-26 to shareholders of Company including book closure intimation etc.
1 day agoAnnual Report for the FY 2025-26
1 day agoAnnual Report for the FY 2025-26
1 day agoNotice of 52nd Annual General Meeting of the Company . Remote-E-voting/E-voting and other information
1 day agoNotice of 52nd Annual General Meeting of the Company . Remote-E-voting/E-voting and other information
1 day agoPublication of notice in newspaper for updation of email id and enabling temporary facility for updation of email Id by shareholders with Evoting agency/ Video Conferencing agency for ensuing 52nd AGM of Company
2 weeks agoPublication of notice in newspaper for updation of email id and enabling temporary facility for updation of email Id by shareholders with Evoting agency/ Video Conferencing agency for ensuing 52nd AGM of Company
2 weeks agoCopy of Newspaper publication of Un-audited financial results (both standalone and consolidated) for the quarter ended 30th June 2026
2 weeks agoCopy of Newspaper publication of Un-audited financial results (both standalone and consolidated) for the quarter ended 30th June 2026
2 weeks agoOutcome of Board meeting held on 13th August 2026
3 weeks agoOutcome of Board meeting held on 13th August 2026
3 weeks agoapproved un-audited financial results (both standalone and consolidated) for the 1st quarter of FY 2026-27 ended on 30.06.2026
3 weeks agoapproved un-audited financial results (both standalone and consolidated) for the 1st quarter of FY 2026-27 ended on 30.06.2026
3 weeks agoSunil Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 inter alia to consider and approve Board Meeting scheduled to be held on 13.08.2026 pursuant to Regulation 29 read with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 inter alia to consider approve and take on record the Un-Audited Financial Results (both standalone and consolidated) for the 1st quarter of FY 2026-27 ended on June 30 2026.
1 month agoSunil Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 inter alia to consider and approve Board Meeting scheduled to be held on 13.08.2026 pursuant to Regulation 29 read with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 inter alia to consider approve and take on record the Un-Audited Financial Results (both standalone and consolidated) for the 1st quarter of FY 2026-27 ended on June 30 2026.
1 month agoCompliance Certificate for the 1st quarter of FY 2026-27 ended 30th June 2026 under Reg. 74(5) of SEBI (DP) regulations
1 month agoCompliance Certificate for the 1st quarter of FY 2026-27 ended 30th June 2026 under Reg. 74(5) of SEBI (DP) regulations
1 month agoSpecial window for Transfer and Dematerialisation of Physical Securities
2 months agoSpecial window for Transfer and Dematerialisation of Physical Securities
2 months agoTrading Window Closure Notice for the declaration of Un-audited financial results of the Company for the 1st quarter of FY 2026-27 ended on 30.06.2026
2 months agoTrading Window Closure Notice for the declaration of Un-audited financial results of the Company for the 1st quarter of FY 2026-27 ended on 30.06.2026
2 months agoCopy of newspaper publication dated 31.05.2026 of the financial results for the quarter/year ended 31.03.206
3 months agoCopy of newspaper publication dated 31.05.2026 of the financial results for the quarter/year ended 31.03.206
3 months agoAnnual Secretarial Compliance Report for the Financial year 2025-26
3 months agoAnnual Secretarial Compliance Report for the Financial year 2025-26
3 months agoApproved Audited Financial Results (Standalone and Consolidated) for the quarter/year ended 31.03.2026
3 months agoApproved Audited Financial Results (Standalone and Consolidated) for the quarter/year ended 31.03.2026
3 months agoOutcome of the 269th Board Meeting of the Company held on 29.05.2026
3 months agoOutcome of the 269th Board Meeting of the Company held on 29.05.2026
3 months agoApproved Audited Financial Results (Standalone and Consolidated) for the quarter/year ended March 31 2026
3 months agoApproved Audited Financial Results (Standalone and Consolidated) for the quarter/year ended March 31 2026
3 months agoSunil Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 inter alia to consider and approve Meeting of the Board of Directors of the Company is scheduled to be held on Friday May 29 2026 at Registered office 38E/252A Vijay Tower 3rd Floor Panchsheel Commercial Complex Shahpur Jat New Delhi-110049 (deemed venue) through video conferencing/Audio visual connection inter alia to consider approve and take on record the Audited Financial Results (both standalone and consolidated) for the 4th quarter of FY 2025-26 and for the Financial year 2025-26 ended on March 31 2026.
3 months agoSunil Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 inter alia to consider and approve Meeting of the Board of Directors of the Company is scheduled to be held on Friday May 29 2026 at Registered office 38E/252A Vijay Tower 3rd Floor Panchsheel Commercial Complex Shahpur Jat New Delhi-110049 (deemed venue) through video conferencing/Audio visual connection inter alia to consider approve and take on record the Audited Financial Results (both standalone and consolidated) for the 4th quarter of FY 2025-26 and for the Financial year 2025-26 ended on March 31 2026.
3 months ago<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Sunil Healthcare Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L24302DL1973PLC189662</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>19.08</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>BB+</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>CARE RATINGS LIMITED</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: SATYENDU PATTNAIK <br/> Designation: COMPANY SECRETARY AND COMPLIANCE OFFICER <br/> EmailId: [email protected]</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: PAWAN RATHI <br/> Designation: CHIEF FINANCIAL OFFICER <br/> EmailId: [email protected]</div> </div> <div> <br/> Date: 24/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>
4 months ago<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Sunil Healthcare Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L24302DL1973PLC189662</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>19.08</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>BB+</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>CARE RATINGS LIMITED</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: SATYENDU PATTNAIK <br/> Designation: COMPANY SECRETARY AND COMPLIANCE OFFICER <br/> EmailId: [email protected]</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: PAWAN RATHI <br/> Designation: CHIEF FINANCIAL OFFICER <br/> EmailId: [email protected]</div> </div> <div> <br/> Date: 24/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>
4 months agoCompliance Certificate under Regulation 40(10) of SBI LODR for the year ended 31st March 2026
4 months agoCompliance Certificate under Regulation 40(10) of SBI LODR for the year ended 31st March 2026
4 months agoCompliance Certificate u/r 74(5) of SEBI (DP) Regulations 2018 for the quarter ended 31st March 2026
4 months agoCompliance Certificate u/r 74(5) of SEBI (DP) Regulations 2018 for the quarter ended 31st March 2026
4 months agoIntimation of Closure of Trading Window for the declaration of audited financial results for the 4th quarter/ financial year ended 31.03.2026
5 months agoIntimation of Closure of Trading Window for the declaration of audited financial results for the 4th quarter/ financial year ended 31.03.2026
5 months agoNewspaper clippings regarding publication of un-audited financial results for 3rd quarter/9 months ended 31st December 2025 (both standalone and consolidated)
6 months agoPursuant to Regulation 30 of the SEBI (LODR) Regulations 2015 we are pleased to inform that the Board of Directors of the Company at their Board Meeting held on Friday February 06 2026 interalia approved Un-Audited Financial Results (standalone and consolidated) for the 3rd quarter/ nine months ended December 31 2025 of the FY 2025-26.
6 months agoBoard at its meeting held today interalia approved Unaudited Financial Results (both standalone and consolidated) for the quarter and nine months ended 31.12.2025 of FY 2025-26
6 months agoSunil Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2026 inter alia to consider and approve Intimation of Board Meeting scheduled to be held on 6th February 2026 to consider interalia un-audited financial results (standalone and consolidated) for the 3rd quarter/9 months ended 31.12.2025 of FY 2025-26
7 months agoCompliance certificate under Regulation 74(5) of SEBI (DP) regulations 2018 for quarter ended 31.12.2025
8 months agoTrading window of the Company shall remain close from January 01 2026 till 48 hours after the declaration of the un-audited financial results for the 3rd quarter/nine months of financial year 2025-26 ended on 31st December 2025
8 months agoCopy of newspaper publication dated 06.11.2025 (both hindi and english) regarding un-audited financial results for the quarter/half year ended 30.09.2025
10 months agoBoard of Directors at its meeting held today on 04.11.2025 interalia approved un-audited financial results(both standalone and consolidated) for the quarter/half year ended 30.09.2025
10 months agoAnnual reports
Concalls & investor presentations
No presentations found
Corporate Actions
Date
Type
Details
No data available.
Company details
Registered office
38 E / 252 - A , Vijay Tower Panchsheel Commercial Complex Shahpurjat New Delhi Delhi PIN: 110049 Tel No: 011-49435555/00 Fax No: 011-43850087 Email: [email protected] Internet: www.sunilhealthcare.com
Registrars
Alankit House , 4 E/2, Jhandewala Extension,New Delhi Alankit House , 4 E/2 Jhandewala Extension NULL PIN: Tel No: 91-11-4254 1234 Fax No: 91-11- 4154 3474 Email: [email protected] Internet: www.alankit.com
Management
Satyendu Pattnaik, Company Secretary & Compliance Officer, DGM Legal
Anil Khaitan, Chairman & Managing Director, Chief Executive Officer
Anil Khaitan, Chairman & Managing Director, Chief Executive Officer
Rakesh Mohan, Non Executive Independent Director
Sanjay Kumar Kaushik, Non Independent & Non Executive Director
Harish Pal Kumar, Non Executive Independent Director
Krishna Venkatachalam Rajan, Non Independent & Non Executive Director
Bejon Kumar Misra, Non Executive Independent Director
Jai Prakash Singh, Non Executive Independent Director
Mudita Chaturvedi, Non Executive Independent Director
Details
BSE 537253
NSE SUNLOC
ISIN INE671C01016